R&D pipeline | Immunotherapies | eTheRNA immunotherapies NV

// immunotherapies

Our R&D Pipeline

TriMix
Lipid Nanoparticles
Oncolysis
Tumor microenvironment modulating technology

LEARN MORE

Melanoma
HPV+ cancer
Kidney cancer
Other indications

LEARN MORE

eTheRNA is developing mRNA-based products mimicking the action of oncolytic viruses.

LEARN MORE

eTheRNA has formed a consortium with North American and European partners to access tools to develop a novel mRNA vaccine against SARS-CoV-2.

LEARN MORE

Galileilaan 19, 2845 Niel, Belgium

+32 3 369 17 40